Philippe Hantson, MD, PhD, is affiliated with the Department of Intensive Care and the Louvain Centre for Toxicology and Applied Pharmacology at Université Catholique de Louvain in Brussels, Belgium. His publications focus on addiction and genetics, specifically addressing topics such as trazodone overdose treatment and the role of cytochrome 2D6 polymorphism in serotonin toxicity recurrence. Hantson has contributed to Psychiatrist.com from 2019 to 2022 and frequently collaborates with co-authors including Vincent Haufroid and Pierre-François Laterre.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
